Article
Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective.
Neuropharmacology - 1 Aug 2016
Andersen Natalia D, Nielsen Beatriz E, Corradi Jeremías, Tolosa María F, Feuerbach Dominik, Arias Hugo R, Bouzat Cecilia
Abstract excerpt
Enhancement of α7 nicotinic receptor (nAChR) function by positive allosteric modulators (PAMs) is a promising therapeutic strategy to improve cognitive deficits. PAMs have been classified only on the basis of their macroscopic effects as type I, which only enhance agonist-induced currents, and type II, which also decrease desensitization and reactivate desensitized nAChRs. To decipher the molecular basis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
